Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Thomas Herold

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients With ROS1-Positive Metastatic Lung Cancer

Journal of Thoracic Oncology

English

Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients

PLoS ONE

Multidisciplinary

2014

English

Related publications

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

English

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

English

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P3.13-27 Clinical Outcomes of Patients With Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center

Journal of Thoracic Oncology

English

P075 Hippo-Yap Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer

Journal of Thoracic Oncology

English

Prevalence of Epidermal Growth Factor Mutations in Patients With Non-Small Cell Lung Cancer in Turkish Population

Balkan Medical Journal

Medicine

2017

English

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients

Asian Pacific Journal of Cancer Prevention

2019

English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Thomas Herold

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients With ROS1-Positive Metastatic Lung Cancer

Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients

Related publications

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

P3.13-27 Clinical Outcomes of Patients With Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center

P075 Hippo-Yap Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer

Prevalence of Epidermal Growth Factor Mutations in Patients With Non-Small Cell Lung Cancer in Turkish Population

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer